The Pro12Ala and C-681G variants of the PPARG locus are associated with opposing growth phenotypes in young schoolchildren

Diabetologia

Volumn 48, Issue 8, 2005, Pages 1496-1502

  Cecil, J E ^a   Fischer, B ^b   Doney, A S F ^b   Hetherington, M ^c   Watt, P ^d   Wrieden, W ^b   Bolton Smith, C ^e   Palmer, C N A ^b  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY OF BRIGHTON   (United Kingdom)

^e MRC Human Nutrition Reseach   (United Kingdom)

Author keywords

Body mass; Children; Growth; Height; Human genetics; Obesity

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

AGE DISTRIBUTION; AMINO ACID SEQUENCE; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENERGY; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; RECORDING; STANDARDIZATION; STATISTICAL SIGNIFICANCE;

ALLELES; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHILD; DNA; ENERGY METABOLISM; FEMALE; GENOTYPE; GREAT BRITAIN; GROWTH; HAPLOTYPES; HUMANS; MALE; OBESITY; PHENOTYPE; PPAR GAMMA;

EID: 23844527870     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1817-0     Document Type: Article

References (36)

1. Lobstein T, Frelut ML (2003) Prevalence of overweight among children in Europe. Obes Rev 4:195-200
2. Lobstein TJ, James WP, Cole TJ (2003) Increasing levels of excess weight among children in England. Int J Obes Relat Metab Disord 27:1136-1138
3. Chinn S, Rona RJ (2001) Prevalence and trends in overweight and obesity in three cross sectional studies of British Children, 1974-94. BMJ 322:24-26
4. Neel JV (1962) Diabetes mellitus: a 'thrifty' genotype rendered detrimental by 'progress'? Am J Hum Genet 14:353-362
5. Auwerx J (1999) PPARgamma, the ultimate thrifty gene. Diabetologia 42:1033-1049
6. Rosen ED, Hsu CH, Wang X et al (2002) C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 16:22-26
7. Agarwal AK, Garg A (2002) A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J Clin Endocrinol Metab 87:408-411
8. Hegele RA, Cao H, Frankowski C, Mathews ST, Leff T (2002) PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes 51:3586-3590
9. Savage DB, Tan GD, Acerini CL et al (2003) Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes 52:910-917
10. Yen CJ, Beamer BA, Negri C et al (1997) Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 241:270-274
11. Deeb SS, Fajas L, Nemoto M et al (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287
12. Altshuler D, Hirschhorn JN, Klannemark M et al (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80
13. Doney AS, Fischer B, Cecil JE et al (2004) Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to type 2 diabetes. Diabetologia 47:555-558
14. Doney A, Fischer B, Frew D et al (2002) Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet 3:21
15. Robitaille J, Despres JP, Perusse L, Vohl MC (2003) The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study. Clin Genet 63:109-116
16. Memisoglu A, Hu FB, Hankinson SE et al (2003) Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet 12:2923-2929
17. Luan J, Browne PO, Harding AH et al (2001) Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 50:686-689
18. Marti A, Corbalan MS, Martinez-Gonzalez MA, Forga L, Martinez JA (2002) CHO intake alters obesity risk associated with Pro12Ala polymorphism of PPARgamma gene. J Physiol Biochem 58:219-220
19. Franks PW, Luan J, Browne PO et al (2004) Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level? Metabolism 53:11-16
20. Valve R, Sivenius K, Miettinen R et al (1999) Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 84:3708-3712
21. Meirhaeghe A, Fajas L, Helbecque N et al (1998) A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet 7:435-440
22. Chao TH, Li YH, Chen JH et al (2004) The 161TT genotype in the exon 6 of peroxisome proliferator-activated receptor gamma gene is associated with premature acute myocardial infarction and increased lipid peroxidation in habitual heavy smokers. Clin Sci (Lond) 107:461-466
23. Wang XL, Oosterhof J, Duarte N (1999) Peroxisome proliferator-activated receptor gamma C161→T polymorphism and coronary artery disease. Cardiovasc Res 44:588-594
24. Meirhaeghe A, Fajas L, Gouilleux F et al (2003) A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population. Arterioscler Thromb Vasc Biol 23:289-294
25. Rieusset J, Seydoux J, Anghel SI et al (2004) Altered growth in male peroxisome proliferator-activated receptor gamma (PPARgamma) heterozygous mice: involvement of PPARgamma in a negative feed-back regulation of growth hormone action. Mol Endocrinol 18:2363-2377
26. Pihlajamaki J, Vanhala M, Vanhala P, Laakso M (2004) The Pro12Ala polymorphism of the PPAR gamma 2 gene regulates weight from birth to adulthood. Obes Res 12:187-190
27. Doney AS, Fischer B, Cecil JE et al (2003) Male preponderance in early diagnosed type 2 diabetes is associated with the ARE insertion/deletion polymorphism in the PPP1R3A locus. BMC Genet 4:11
28. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989
29. Zhao JH (2004) 2LD, GENECOUNTING and HAP: Computer programs for linkage disequilibrium analysis. Bioinformatics 20:1325-1326
30. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA (1995) Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 73:17-24
31. Cole TJ, Freeman JV, Preece MA (1995) Body mass index reference curves for the UK, 1990. Arch Dis Child 73:25-29
32. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240-1243
33. Rodriguez-Esparragon FJ, Rodriguez-Perez JC, Macias-Reyes A, Alamo-Santana F (2003) Peroxisome proliferator-activated receptor-gamma2- Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are associated with essential hypertension. J Hypertens 21:1649-1655
34. Ostgren CJ, Lindblad U, Melander O, Melander A, Groop L, Rastam L (2003) Peroxisome proliferator-activated receptor-gammaPro12Ala polymorphism and the association with blood pressure in type 2 diabetes: Skaraborg Hypertension and Diabetes Project. J Hypertens 21:1657-1662
35. Ridker PM, Cook NR, Cheng S et al (2003) Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction. Arterioscler Thromb Vasc Biol 23:859-863
36. Doney AS, Fischer B, Leese G, Morris AD, Palmer CN (2004) Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus. A Go-DARTS study. Arterioscler Thromb Vasc Biol 24:2403-2407